With this hypothesis and question in mind, we jointly analyzed the clonal distribution, diversity, clonal overlap, and network characteristics of BCR and TCR repertoires in healthy individuals and individuals with disease, including COVID-19 and autoimmune hepatitis (AIH). This evidence concerns the gene BCR and autoimmune hepatitis.